Results 101 to 110 of about 226,507 (202)

Pathways and Molecular Mechanisms Governing LDL Receptor Regulation. [PDF]

Circ Res
Schmidt HM, Jarrett KE, de Aguiar Vallim TQ, Tarling EJ.   +3 more
europepmc   +1 more source

The Constituents of <i>Phyllanthus emblica</i> Fruit Ameliorate Hyperlipidemia Through the Modulation of SREBPs, HMG-CoA Reductase, and LDL Receptor Pathway. [PDF]

Scientifica (Cairo)
Kuddus SA, Shohag MH, Yaseen QI, Ahmed L, Kashfia AT, Islam FB, Khan SI, Karim R, Hossain MM, Alam MA, Khan F.   +10 more
europepmc   +1 more source

ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells. [PDF]

Nat Commun, 2023
Lee J, Lee H, Lee H, Shin M, Shin MG, Seo J, Lee EJ, Park SA, Park S.   +8 more
europepmc   +1 more source

MAM and LDL Receptor Class A Domain Containing 1 Deficiency Aggravates Hepatic Fibrosis in Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

Gastro Hep Adv
Bhattacharjee J, Wang LX, Meneses B, Emamaullee JA, Frey MR, Kohli R.   +5 more
europepmc   +1 more source

Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cells. [PDF]

Sci Rep, 2023
Kawamata T, Wakimoto A, Nishikawa T, Ikezawa M, Hamada M, Inoue Y, Kulathunga K, Salim FN, Kanai M, Nishino T, Gentleman K, Liu C, Mathis BJ, Obana N, Fukuda S, Takahashi S, Taya Y, Sakai S, Hiramatsu Y.   +18 more
europepmc   +1 more source

Enhanced lymphocyte infiltration in the liver of LDL receptor and Myeloid Differentiation 1 double knockout mice on high fat diet. [PDF]

Sci Rep
Biswas M, Tomono S, Kasai K, Takagi H, Inui M, Basak B, Nagaoka F, Yamazaki T, Morita N, Okumura A, Akashi-Takamura S.   +10 more
europepmc   +1 more source

A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD. [PDF]

Cells, 2023
Srivastava RAK.
europepmc   +1 more source

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation. [PDF]

Cardiovasc Res
Velagapudi S, Miranda MX, Adla P, Kraler S, Mohammed SA, Baki S, Robert J, Rohrer L, Lee H, Jang HD, Obeid S, Tailleux A, Staels B, Sepuri NBV, Paneni F, Gutti RK, von Eckardstein A, Kim HS, Akhmedov A, Camici GG, Lüscher TF.   +20 more
europepmc   +1 more source

Cold shock domain-containing protein E1 is a posttranscriptional regulator of the LDL receptor. [PDF]

Sci Transl Med, 2022
Smith GA, Padmanabhan A, Lau BH, Pampana A, Li L, Lee CY, Pelonero A, Nishino T, Sadagopan N, Xia VQ, Jain R, Natarajan P, Wu RS, Black BL, Srivastava D, Shokat KM, Chorba JS.   +16 more
europepmc   +1 more source

Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Alkhairy A, Xiang P, Khoo JK, Taylor CM, Francis GA.   +4 more
europepmc   +1 more source